adenosine

Product NDC: 25021-301
11-digit product format: 250210301
Labeler code: 25021
Product ID: 25021-301_a40e7fe9-478d-4916-9657-5eba074215f0
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: adenosine
Dosage form: INJECTION
Route: INTRAVENOUS
Labeler: Sagent Pharmaceuticals
Application: ANDA077283
Marketing category: ANDA
Marketing start: 2014-04-16
Substance: ADENOSINE
Active strength: 3 mg/mL
Pharmacologic classes: Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 6 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	25021-301		D	Discontinued by firm	2026-08-07
excluded product	product	25021-301		D	Discontinued by firm	2026-08-07
excluded package	package	25021-301	25021-301-02	D	Discontinued by firm	2026-08-07
excluded package	package	25021-301	25021-301-04	D	Discontinued by firm	2026-08-07
excluded package	package	25021-301	25021-301-72	D	Discontinued by firm	2026-08-07
excluded package	package	25021-301	25021-301-76	D	Discontinued by firm	2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 72 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	25021-301-76	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	25021-301-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	25021-301-72	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	25021-301-04	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	25021-301-76	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	25021-301-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	25021-301-72	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	25021-301-04	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	25021-301-76	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	25021-301-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	25021-301-72	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	25021-301-04	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	25021-301-76	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	25021-301-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	25021-301-72	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	25021-301-04	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	25021-301-76	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	25021-301-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	25021-301-72	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	25021-301-04	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	25021-301-76	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	25021-301-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	25021-301-72	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	25021-301-04	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	25021-301-76	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	25021-301-02	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	25021-301-72	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	25021-301-04	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	25021-301-76	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	25021-301-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	25021-301-72	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	25021-301-04	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	25021-301-76	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	25021-301-02	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	25021-301-72	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	25021-301-04	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	25021-301-76	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	25021-301-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	25021-301-72	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	25021-301-04	`ad56d346431e…`	`cc804d4bbf1e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077283-001	ADENOSINE	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP		2007-06-14

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A077283-001	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A077283-001	ADENOSINE	3MG/ML	INJECTABLE / INJECTION	AP	2007-06-14	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A077283-001	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077283-001	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077283-001	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077283-001	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077283-001	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077283-001	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077283-001	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077283-001	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077283-001	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077283-001	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077283-001	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077283-001	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077283-001	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077283-001	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077283-001	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077283-001	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077283-001	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077283-001	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077283-001	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077283-001	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077283-001	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A077283-001	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A077283-001	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A077283-001	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A077283-001	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077283-001	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077283-001	AP	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A077283-001	AP	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A077283-001	AP	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A077283-001	AP	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A077283-001	AP	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A077283-001	AP	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A077283-001	AP	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A077283-001	AP	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A077283-001	AP	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A077283-001	AP	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A077283-001	AP	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A077283-001	AP	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A077283-001	AP	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A077283-001	AP	1	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: adenosine
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ADENOSINE	3 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
K72T3FS567	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
727355	Internal RxNorm lookup
727360	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
5a55b45d-9cee-4c0c-9e44-021dbf70a018	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d676a241-be05-4740-b3ee-1a5f2ed422d2	Product name	4	20180615
dd8bd48f-20d6-43c7-b471-3ae872868afa	Product name	3	20180125
d41954ff-bc63-4b2c-aba0-9146707659d7	Product name	2	20151117

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
25021-301-67	adenosine	10 in 1 CARTON	INJECTION	10	5
25021-301-67	adenosine	2 mL in 1 SYRINGE	INJECTION	2	5
25021-301-68	adenosine	10 in 1 CARTON	INJECTION	10	5
25021-301-68	adenosine	4 mL in 1 SYRINGE	INJECTION	4	5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
25021-301-02	ML - Milliliter	25021-301	3729e686-fc62-41ed-855e-a39f4402e011	1	2012-07-24
25021-301-04	ML - Milliliter	25021-301	9a93cab0-4602-4ea1-9feb-68b308664b8d	1	2012-07-24
25021-301-67	ML - Milliliter	25021-301	8fcf6346-b3fc-4249-8569-2fe549cb19f4	1	2014-05-02
25021-301-68	ML - Milliliter	25021-301	61dd41e7-ed30-4e32-8fce-35833a52d317	1	2014-04-03
25021-301-72	ML - Milliliter	25021-301	f5dda41a-61b0-4419-8878-7d49e4ebdd7c	1	2012-07-24
25021-301-76	ML - Milliliter	25021-301	669107db-355d-4d80-bcd5-5afb2de45109	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
adenosine	ACTIVE INGREDIENT	K72T3FS567	ADENOSINE INJECTION [SAGENT PHARMACEUTICALS]	3
adenosine	ACTIVE MOIETY	K72T3FS567	ADENOSINE INJECTION [SAGENT PHARMACEUTICALS]	3
sodium chloride	INACTIVE INGREDIENT	451W47IQ8X	ADENOSINE INJECTION [SAGENT PHARMACEUTICALS]	3
water	INACTIVE INGREDIENT	059QF0KO0R	ADENOSINE INJECTION [SAGENT PHARMACEUTICALS]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
25021-301	ADENOSINE INJECTION [SAGENT PHARMACEUTICALS]	5	Current NDC, Legacy NDC, 4 package rows	20241206_5a55b45d-9cee-4c0c-9e44-021dbf70a018.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
adenosine	ADENOSINE	ProPharma Distribution	48d72391-b3d4-bd97-e063-6294a90a9d6f	2026-01-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077283 application number: ANDA077283
adenosine	ADENOSINE	Sagent Pharmaceuticals	5a55b45d-9cee-4c0c-9e44-021dbf70a018	2024-12-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077283 application number: ANDA077283 ndc (product): 25021-301
ADENOSINE	ADENOSINE	HF Acquisition Co LLC, DBA HealthFirst	b973bce7-0500-63a2-e053-2a95a90af9e2	2021-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077283 application number: ANDA077283
Adenosine	ADENOSINE	Gland Pharma Limited	ab2edabd-e57d-4754-9822-93bd17af9e88	2017-12-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077283 application number: ANDA077283

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
K72T3FS567	ADENOSINE	58-61-7	ADENOSINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
727355	adenosine 12 MG in 4 ML Prefilled Syringe	PSN	5a55b45d-9cee-4c0c-9e44-021dbf70a018	5
727360	adenosine 6 MG in 2 ML Prefilled Syringe	PSN	5a55b45d-9cee-4c0c-9e44-021dbf70a018	5
727360	2 ML adenosine 3 MG/ML Prefilled Syringe	SCD	5a55b45d-9cee-4c0c-9e44-021dbf70a018	5
727355	4 ML adenosine 3 MG/ML Prefilled Syringe	SCD	5a55b45d-9cee-4c0c-9e44-021dbf70a018	5
727355	adenosine 12 MG per 4 ML Prefilled Syringe	SY	5a55b45d-9cee-4c0c-9e44-021dbf70a018	5
727360	adenosine 6 MG per 2 ML Prefilled Syringe	SY	5a55b45d-9cee-4c0c-9e44-021dbf70a018	5
727355	adenosine 12 MG in 4 ML Prefilled Syringe	PSN	b973bce7-0500-63a2-e053-2a95a90af9e2	2
727355	4 ML adenosine 3 MG/ML Prefilled Syringe	SCD	b973bce7-0500-63a2-e053-2a95a90af9e2	2
727355	adenosine 12 MG per 4 ML Prefilled Syringe	SY	b973bce7-0500-63a2-e053-2a95a90af9e2	2
727360	adenosine 6 MG in 2 ML Prefilled Syringe	PSN	48d72391-b3d4-bd97-e063-6294a90a9d6f	1
727360	2 ML adenosine 3 MG/ML Prefilled Syringe	SCD	48d72391-b3d4-bd97-e063-6294a90a9d6f	1
727360	adenosine 6 MG per 2 ML Prefilled Syringe	SY	48d72391-b3d4-bd97-e063-6294a90a9d6f	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
25021-301-67	25021030167	10 SYRINGE in 1 CARTON (25021-301-67) / 2 mL in 1 SYRINGE	10 syringe	2014-04-16	0000-00-00	No	No	Current
25021-301-68	25021030168	10 SYRINGE in 1 CARTON (25021-301-68) / 4 mL in 1 SYRINGE	10 syringe	2014-04-16	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Adenosine Injection, USP For Rapid Bolus Intravenous Use	ProPharma Distribution	2026-01-20	HUMAN PRESCRIPTION DRUG LABEL	1
Adenosine Injection, USP For Rapid Bolus Intravenous Use	Sagent Pharmaceuticals	2024-12-04	HUMAN PRESCRIPTION DRUG LABEL	5
ADENOSINE INJECTION, USP 12mg PER 4mL (3mg PER mL) 4mL SYR	HF Acquisition Co LLC, DBA HealthFirst	2021-01-22	HUMAN PRESCRIPTION DRUG LABEL	2